"10.1371_journal.pone.0000097","plos one","2006-12-20T00:00:00Z","Reijo Laaksonen; Mikko Katajamaa; Hannu Päivä; Marko Sysi-Aho; Lilli Saarinen; Päivi Junni; Dieter Lütjohann; Joél Smet; Rudy Van Coster; Tuulikki Seppänen-Laakso; Terho Lehtimäki; Juhani Soini; Matej Orešič","Research Unit, University Hospital of Tampere, Tampere, Finland; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland; Department of Internal Medicine, University Hospital of Tampere, Tampere, Finland; VTT Technical Research Centre of Finland, Espoo, Finland; Department of Clinical Pharmacology, University of Bonn, Bonn, Germany; Department of Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent, Belgium; Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere, Finland; Centre for Laboratory Medicine, University Hospital of Tampere, Tampere, Finland; Medical School, University of Tampere, Tampere, Finland","Conceived and designed the experiments: MO RL. Performed the experiments: TS HP JS. Analyzed the data: MO RL MK MS LS PJ. Contributed reagents/materials/analysis tools: MO TS HP DL JS Rv TL JS. Wrote the paper: MO RL MK MS.","Drs. Orešič, Laaksonen, Päivä, and Lehtimäki are named inventors in a patent application to use metabolomics technology for screening of myopathy risk.","2006","12","Reijo Laaksonen","RL",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
